Cargando…
Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640813/ https://www.ncbi.nlm.nih.gov/pubmed/26554703 http://dx.doi.org/10.1371/journal.pone.0142802 |
| _version_ | 1782400120747196416 |
|---|---|
| author | Greenberg, Richard N Hurley, Maria Yadira Dinh, Dinh V. Mraz, Serena Vera, Javier Gomez von Bredow, Dorothea von Krempelhuber, Alfred Roesch, Siegfried Virgin, Garth Arndtz-Wiedemann, Nathaly Meyer, Thomas Peter Schmidt, Darja Nichols, Richard Young, Philip Chaplin, Paul |
| author_facet | Greenberg, Richard N Hurley, Maria Yadira Dinh, Dinh V. Mraz, Serena Vera, Javier Gomez von Bredow, Dorothea von Krempelhuber, Alfred Roesch, Siegfried Virgin, Garth Arndtz-Wiedemann, Nathaly Meyer, Thomas Peter Schmidt, Darja Nichols, Richard Young, Philip Chaplin, Paul |
| author_sort | Greenberg, Richard N |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4640813 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46408132015-11-13 Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis Greenberg, Richard N Hurley, Maria Yadira Dinh, Dinh V. Mraz, Serena Vera, Javier Gomez von Bredow, Dorothea von Krempelhuber, Alfred Roesch, Siegfried Virgin, Garth Arndtz-Wiedemann, Nathaly Meyer, Thomas Peter Schmidt, Darja Nichols, Richard Young, Philip Chaplin, Paul PLoS One Correction Public Library of Science 2015-11-10 /pmc/articles/PMC4640813/ /pubmed/26554703 http://dx.doi.org/10.1371/journal.pone.0142802 Text en © 2015 Greenberg et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
| spellingShingle | Correction Greenberg, Richard N Hurley, Maria Yadira Dinh, Dinh V. Mraz, Serena Vera, Javier Gomez von Bredow, Dorothea von Krempelhuber, Alfred Roesch, Siegfried Virgin, Garth Arndtz-Wiedemann, Nathaly Meyer, Thomas Peter Schmidt, Darja Nichols, Richard Young, Philip Chaplin, Paul Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis |
| title | Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis |
| title_full | Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis |
| title_fullStr | Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis |
| title_full_unstemmed | Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis |
| title_short | Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis |
| title_sort | correction: a multicenter, open-label, controlled phase ii study to evaluate safety and immunogenicity of mva smallpox vaccine (imvamune) in 18-40 year old subjects with diagnosed atopic dermatitis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640813/ https://www.ncbi.nlm.nih.gov/pubmed/26554703 http://dx.doi.org/10.1371/journal.pone.0142802 |
| work_keys_str_mv | AT greenbergrichardn correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT hurleymariayadira correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT dinhdinhv correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT mrazserena correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT verajaviergomez correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT vonbredowdorothea correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT vonkrempelhuberalfred correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT roeschsiegfried correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT virgingarth correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT arndtzwiedemannnathaly correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT meyerthomaspeter correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT schmidtdarja correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT nicholsrichard correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT youngphilip correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis AT chaplinpaul correctionamulticenteropenlabelcontrolledphaseiistudytoevaluatesafetyandimmunogenicityofmvasmallpoxvaccineimvamunein1840yearoldsubjectswithdiagnosedatopicdermatitis |